The L-ergothioneine (EGT) market has gained significant momentum in recent years owing to increasing demand from the medical sector. EGT is an amino acid and potent antioxidant that is synthesized naturally by some fungi and present in foods like mushrooms. It helps scavenge free radicals and reactive oxygen species in the body. The medical uses of EGT include treatment of neurological disorders, cardiovascular diseases, diabetes, and cancer. EGT has also shown efficacy in reducing oxidative stress and inflammation.

The Global L-Ergothioneine (EGT) Market is estimated to be valued at US$ 47.01 Bn in 2024 and is expected to exhibit a CAGR of 11% over the forecast period 2024 To 2031.

Key Takeaways Key players operating in the L-ergothioneine (EGT) market are Lockheed Martin Corporation (US), Northrop Grumman Corporation (US), Raytheon Company (US), Thales Group (France).

Growing demand from the pharmaceutical industry is one of the major factors driving the growth of the L-Ergothioneine (EGT) Market Size Many clinical studies have demonstrated the effectiveness of EGT in treating neurodegenerative diseases and reducing the side effects of cancer treatment. This is increasing its uptake in various drugs.

Technological advancements in fermentation processes have enabled large-scale production of EGT through microbial fermentation. Previously, EGT could only be extracted from natural sources in minute quantities. Development of efficient fermentation techniques using eukaryotic microbes has significantly boosted the commercial production of EGT.

Get More Insights On, L-Ergothioneine (EGT) Market

Explore More Related Topic On, Blast Resistant And Bulletproof Buildings Market